Collagenase-3 expression by tumor cells and gelatinase B expression by stromal fibroblast-like cells are associated with biochemical recurrence after radical prostatectomy in patients with prostate cancer

[1] Egeblad M(2002)New functions for the matrix metalloproteinases in cancer progression Nat Rev Cancer 2 161-174

[2] Werb Z(2000)Demonstration in vivo that stromelysin-3 functions through its proteolytic activity Oncogene 19 1605-1612

[3] Noel A(1999)Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention J Clin Invest 103 1237-1241

[4] Boulay A(2001)Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosis Neoplasia 3 459-468

[5] Kebers F(2002)Complex roles of tissue inhibitors of metalloproteinases in cancer Oncogene 21 2245-2252

[6] Kannan R(2005)Tissue inhibitor of metalloproteinases-1 in breast cancer Endocr Relat Cancer 12 215-227

[7] Hajitou A(1998)Immunolocalization of apolipoprotein D, androgen receptor and prostate specific antigen in early stage prostate cancers J Urol 159 548-554

[8] Calberg-Bacq CM(2005)Identification of degradome components associated with prostate cancer progression by expression analysis of human prostatic tissues Br J Cancer 92 2171-2180

[9] Basset P(2005)Matrix metalloproteinases as diagnostic (MMP-13) and prognostic (MMP-2, MMP-9) markers of prostate cancer Urol Res 33 44-50

[10] Rio MC(2005)Prognostic value of stromal immunolabelling by MMP-2, MT1-MMP and TIMP-2 in clinically localized prostate cancer Prog Urol 15 250-254

[1] Egeblad M(2002)New functions for the matrix metalloproteinases in cancer progression Nat Rev Cancer 2 161-174

[2] Werb Z(2000)Demonstration in vivo that stromelysin-3 functions through its proteolytic activity Oncogene 19 1605-1612

[3] Noel A(1999)Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention J Clin Invest 103 1237-1241

[4] Boulay A(2001)Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosis Neoplasia 3 459-468

[5] Kebers F(2002)Complex roles of tissue inhibitors of metalloproteinases in cancer Oncogene 21 2245-2252

[6] Kannan R(2005)Tissue inhibitor of metalloproteinases-1 in breast cancer Endocr Relat Cancer 12 215-227

[7] Hajitou A(1998)Immunolocalization of apolipoprotein D, androgen receptor and prostate specific antigen in early stage prostate cancers J Urol 159 548-554

[8] Calberg-Bacq CM(2005)Identification of degradome components associated with prostate cancer progression by expression analysis of human prostatic tissues Br J Cancer 92 2171-2180

[9] Basset P(2005)Matrix metalloproteinases as diagnostic (MMP-13) and prognostic (MMP-2, MMP-9) markers of prostate cancer Urol Res 33 44-50

[10] Rio MC(2005)Prognostic value of stromal immunolabelling by MMP-2, MT1-MMP and TIMP-2 in clinically localized prostate cancer Prog Urol 15 250-254